Your browser doesn't support javascript.
loading
A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.
Penning, Louis C; Berenguer, Marina; Czlonkowska, Anna; Double, Kay L; Dusek, Petr; Espinós, Carmen; Lutsenko, Svetlana; Medici, Valentina; Papenthin, Wiebke; Stremmel, Wolfgang; Willemse, Jose; Weiskirchen, Ralf.
Afiliação
  • Penning LC; Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, 3584 CM Utrecht, The Netherlands.
  • Berenguer M; Digestive Medicine Department, Ciberehd & IISLaFe, Hospital U. i P. La Fe, University of Valencia, 46010 Valenci, Spain.
  • Czlonkowska A; Second Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.
  • Double KL; Brain and Mind Centre and School of Medical Sciences (Neuroscience), The University of Sydney, Sydney, NSW 2006, Australia.
  • Dusek P; Department of Radiology, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Espinós C; Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic.
  • Lutsenko S; Rare Neurodegenerative Diseases Lab, Centro de Investigacion Principe Felipe, 46012 Valencia, Spain.
  • Medici V; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 1800, USA.
  • Papenthin W; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 1800, USA.
  • Stremmel W; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California Davis, Sacramento, CA 59817, USA.
  • Willemse J; German Society for Wilson disease Patients (Morbus Wilson e.V.), Zehlendorfer Damm 119, D-14532 Kleinnachnow, Germany.
  • Weiskirchen R; Private Practice for Internal Medicine, Beethovenstraße 2, D-76530 Baden-Baden, Germany.
Biomedicines ; 11(2)2023 Feb 01.
Article em En | MEDLINE | ID: mdl-36830958
ABSTRACT
Wilson disease (WD) is a rare, inherited metabolic disorder manifested with varying clinical presentations including hepatic, neurological, psychiatric, and ophthalmological features, often in combination. Causative mutations in the ATP7B gene result in copper accumulation in hepatocytes and/or neurons, but clinical diagnosis remains challenging. Diagnosis is complicated by mild, non-specific presentations, mutations exerting no clear effect on protein function, and inconclusive laboratory tests, particularly regarding serum ceruloplasmin levels. As early diagnosis and effective treatment are crucial to prevent progressive damage, we report here on the establishment of a global collaboration of researchers, clinicians, and patient advocacy groups to identify and address the outstanding challenges posed by WD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Biomedicines Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Biomedicines Ano de publicação: 2023 Tipo de documento: Article